Editorial Expression of Concern: Birinapant Sensitizes Platinum-Resistant Carcinomas With High Levels of cIAP to Carboplatin Therapy

npj Precision Oncology

doi 10.1038/s41698-018-0062-1

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Birinapant Sensitizes Platinum-Resistant Carcinomas With High Levels of cIAP to Carboplatin Therapy

Gynecologic Oncology
GynecologyOncologyObstetrics
2017English

Editorial Expression of Concern for Multiple Articles

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

816 Autophagy Inhibition Sensitizes Targeted Therapy-Resistant Melanoma to MEK1/2 Inhibitors

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Expression of Concern

Cellular and Molecular Neurobiology
MedicineMolecular NeuroscienceCell BiologyCellular
2019English

Expression of Concern

Immunopharmacology and Immunotoxicology
MedicineToxicologyAllergyImmunologyPharmacology
2020English

Expression of Concern

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2020English

Evaluation of Novel Ammine/Amine Platinum (IV) Dicarboxylates in L1210 Murine Leukaemia Cells Sensitive and Resistant to Cisplatin, Tetraplatin or Carboplatin

British Journal of Cancer
Cancer ResearchOncology
1994English

Sinomenine Sensitizes Multidrug-Resistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression

PLoS ONE
Multidisciplinary
2014English

An Expression of Concern

Influenza and other Respiratory Viruses
EnvironmentalPublic HealthEpidemiologyPulmonaryInfectious DiseasesRespiratory MedicineOccupational Health
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy